RxDoctor Payments DataLook up a doctor →

Ronak Jani, MD

Neurology · Cookeville, TNNPI 1417182304

Payments from drug & device makers

$86,741in general payments, 2019–2025

Across 1,383 payments — averaging $62.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$66K
  • UCB, Inc.$3K
  • Amgen$1K
  • SK Life Science, Inc.$1K
  • Novartis$1K
  • Pfizer$1K
  • plus $13K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)331$65,774
UCB, Inc.141$3,311
Amgen51$1,394
SK Life Science, Inc.40$1,133
Novartis56$1,088
Pfizer70$1,055
Teva Pharmaceuticals USA, Inc.61$927
Lilly USA, LLC48$877
Supernus Pharmaceuticals, Inc.63$869
MDD US Operations, LLC38$820
Jazz Pharmaceuticals Inc.33$816
Acadia Pharmaceuticals Inc38$749
Argenx US, Inc.26$691
Biohaven Pharmaceutical Holding Company Ltd.37$539
Biohaven Pharmaceuticals, Inc.30$525
Neurocrine Biosciences, Inc.20$460
Lundbeck LLC22$456
Eisai Inc.17$399
Livanova USA, Inc.18$386
Sunovion Pharmaceuticals Inc.27$337
Neurelis, Inc.18$307
Biogen15$302
Adamas Pharmaceuticals, Inc.18$279
Boston Scientific11$265
Takeda Pharmaceuticals U.S.A., Inc.11$232
AstraZeneca10$226
Johnson & Johnson(2 entities)6$221
Amneal Pharmaceuticals LLC12$196
Arbor Pharmaceuticals, Inc.13$182
Impel Pharmaceuticals Inc.6$169
Azurity Pharmaceuticals, Inc.10$164
Akcea Therapeutics, Inc.5$159
Grifols USA, LLC7$152
Assertio Therapeutics, Inc.12$147
Alnylam Pharmaceuticals Inc.7$119
Aprecia Pharmaceuticals, LLC7$119
Sumitomo Pharma America, Inc.6$100
Acorda Therapeutics, Inc7$99
Avion Pharmaceuticals3$82
Scilex Pharmaceuticals Inc.4$78
Otsuka America Pharmaceutical, Inc.4$64
TG Therapeutics, Inc.3$56
Vanda Pharmaceuticals Inc.2$50
Idorsia Pharmaceuticals US Inc3$49
Sanofi2$46
Avanir Pharmaceuticals, Inc.2$35
Catalyst Pharmaceuticals, Inc.1$35
Upsher-smith Laboratories LLC2$28
Currax Pharmaceuticals LLC2$26
Abbott1$26
Sanofi-aventis U.S. LLC1$25
Nevro Corp.1$24
Impel Pharmaceuticals LLC1$23
Inspire Medical Systems, Inc.1$18
Aucta Pharmaceuticals, Inc.1$17
Kyowa Kirin, Inc.1$14

How this compares

$86,741 in reported general payments places this provider in the 80th percentile of 361 neurology providers in Tennessee.

See all neurology providers in Tennessee

Medicare billing

Part B allowed, 2024
$133,230
Medicare patients
329
Services billed
10,559

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Cookeville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →